A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...
Computational pathology-informed immune biomarker for trastuzumab benefit in HER2+ breast cancer: Validation in NSABP B-41 clinical trial. Analysis of event-free survival (EFS) of stromal tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback